Clinical Trials Logo

Ventricular Dysfunction, Left clinical trials

View clinical trials related to Ventricular Dysfunction, Left.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT03573427 Withdrawn - Clinical trials for Left Ventricular Dysfunction

LV Endocardial CRT for Patients With Intermediate QRS Width

EndoCRT
Start date: April 28, 2016
Phase:
Study type: Observational

This pilot study is designed as a multi-centre cohort study determining the degree of LV reverse remodeling in patients with intermediate QRS widths (120-149ms) who undergo CRT implant with transseptal LV leads, and comparing to the average expected reverse remodeling rate in patients with standard transvenous coronary sinus leads and QRS widths ≥150ms.

NCT ID: NCT02503280 Withdrawn - Clinical trials for Myocardial Infarction

The Transendocardial Autologous Cells (hMSC) or (hMSC) and (hCSC) in Ischemic Heart Failure Trial.

TAC-HFT-II
Start date: March 1, 2025
Phase: Phase 1/Phase 2
Study type: Interventional

Before initiating the full randomized study, a Pilot Safety Phase will be performed. In this phase the composition of cells administered via the Biosense Webster MyoStar NOGA Injection Catheter System will be tested. The randomized portion of the study will be conducted after a full review of the safety data from the pilot Phase by the Data safety monitoring board. Following the Pilot Phase of five (5) Fifty (50) patients scheduled to undergo cardiac catheterization and meeting all inclusion/exclusion criteria will be evaluated at baseline. Patients will be randomized in a 2:2:1 ratio to one of three Treatment Strategies.

NCT ID: NCT02155842 Withdrawn - Clinical trials for Heart Failure, Diastolic

Exercise Training in Treating Diastolic Heart Failure

TREND-HF
Start date: June 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether endurance exercise of either high or moderate intensity can reverse structural and functional changes of the heart in patients with diastolic heart failure, and to investigate which type of exercise is best in terms of aerobe capacity and quality of life. The investigators expect that high intensity endurance exercise is superior to moderate intensity endurance exercise.

NCT ID: NCT01705470 Withdrawn - Clinical trials for Anemia Treatment Among Patients Suffering From Left Ventricular Systolic Dysfunction

Furosemide Treatment Before Blood Transfusion in Patients With Systolic Dysfunction

Start date: October 2012
Phase: N/A
Study type: Interventional

The study Objective is to assess the clinical and echocardiographic changes of patients with systolic dysfunction receiving blood transfusion, with or without prior treatment with furosemide

NCT ID: NCT00213902 Withdrawn - Clinical trials for Ventricular Dysfunction

Clonidine and Left Ventricular Dysfunction

Start date: April 2004
Phase: Phase 2
Study type: Observational

The objectives of this study are: 1. To evaluate the effect of clonidine, a sympathetic modulator, to reverse cardiac remodeling and to improve hemodynamics in diastolic heart failure (DHF). 2. To evaluate the effect of clonidine on neurohormones and quality of life in patients with DHF. The study is a double-blind, placebo-controlled study evaluating the effects of clonidine compared to placebo in patients with DHF. A total of 70 patients with DHF will be randomized in a 1:1 ratio to: 1. placebo (n=35) or to 2. clonidine (n=35) in a dose of 0.075 mg twice a day for the first 6 weeks followed by uptitration to 0.150 mg twice a day for 6 months. The primary outcome is the reversion of cardiac remodeling and hemodynamic parameters evaluated by magnetic resonance imaging (MRI) and echocardiography.